{"count": 3, "results": [{"_id": "37866322", "pmid": 37866322, "title": "Protective role of metformin in preeclampsia via the regulation of NF-kappaB/sFlt-1 and Nrf2/HO-1 signaling pathways by activating AMPK.", "journal": "Placenta", "authors": ["He L", "Wu X", "Zhan F", "Li X", "Wu J"], "date": "2023-10-17T00:00:00Z", "doi": "10.1016/j.placenta.2023.10.003", "meta_date_publication": "2023 Oct 17", "meta_volume": "143", "meta_issue": "", "meta_pages": "91-99", "score": 50243.06, "text_hl": "Moreover, LDH @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@Cytotoxicity@@@ Assay Kit detected the release of LDH, and ROS, @CHEMICAL_3_4_Methylenedioxyamphetamine @CHEMICAL_MESH:D015104 @@@MDA@@@, or @GENE_SOD1 @GENE_6647 @@@SOD@@@ kits detected oxidative stress-related factors. RESULTS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ significantly inhibited @<m>DISEASE_Systemic_Inflammatory_Response_Syndrome</m> @DISEASE_MESH:D018746 @@@inflammatory damage@@@ and oxidative stress responses in @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@-induced @CELLLINE_CVCL:7162 @@@HTR-8/SVneo@@@ cells. ", "citations": {"NLM": "He L, Wu X, Zhan F, Li X, Wu J. Protective role of metformin in preeclampsia via the regulation of NF-kappaB/sFlt-1 and Nrf2/HO-1 signaling pathways by activating AMPK. Placenta. 2023 Oct 17;143():91-99. PMID: 37866322", "BibTeX": "@article{37866322, title={Protective role of metformin in preeclampsia via the regulation of NF-kappaB/sFlt-1 and Nrf2/HO-1 signaling pathways by activating AMPK.}, author={He L and Wu X and Zhan F and Li X and Wu J}, journal={Placenta}, volume={143}, pages={91-99}}"}}, {"_id": "24363693", "pmid": 24363693, "pmcid": "PMC3869592", "title": "Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin", "journal": "Iran J Pharm Res", "authors": ["Panahi Y", "Mojtahedzadeh M", "Beiraghdar F", "Najafi A", "Khajavi MR", "Pazouki M", "Zakeri N", "Saadat A", "Aghamohammadi M"], "date": "2011-01-01T00:00:00Z", "meta_date_publication": "2011 Winter", "meta_volume": "10", "meta_issue": "1", "meta_pages": "141-8", "score": 50053.19, "text_hl": "It was found that mean MACR had positive correlation with @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@BS@@@ levels in traumatized @DISEASE_Critical_Illness @DISEASE_MESH:D016638 @@@critically ill@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Systemic_Inflammatory_Response_Syndrome</m> @DISEASE_MESH:D018746 @@@SIRS@@@ that treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @GENE_INS @GENE_3630 @@@insulin@@@ for three days. ", "citations": {"NLM": "Panahi Y, Mojtahedzadeh M, Beiraghdar F, Najafi A, Khajavi MR, Pazouki M, Zakeri N, Saadat A, Aghamohammadi M. Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin Iran J Pharm Res. 2011 Winter;10(1):141-8. PMID: 24363693", "BibTeX": "@article{24363693, title={Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin}, author={Panahi Y and Mojtahedzadeh M and Beiraghdar F and Najafi A and Khajavi MR and Pazouki M and Zakeri N and Saadat A and Aghamohammadi M}, journal={Iran J Pharm Res}, volume={10}, number={1}, pages={141-8}}"}}, {"_id": "18636232", "pmid": 18636232, "title": "How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.", "journal": "Adv Ther", "authors": ["Ansari G", "Mojtahedzadeh M", "Kajbaf F", "Najafi A", "Khajavi MR", "Khalili H", "Rouini MR", "Ahmadi H", "Abdollahi M"], "date": "2008-07-01T00:00:00Z", "doi": "10.1007/s12325-008-0075-1", "meta_date_publication": "2008 Jul", "meta_volume": "25", "meta_issue": "7", "meta_pages": "681-702", "score": 50039.867, "text_hl": "We designed this study to evaluate the efficacy and safety of a new intensive @GENE_INS @GENE_3630 @@@insulin@@@ therapy (IIT) protocol combined with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. METHODS: Twenty-one @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Systemic_Inflammatory_Response_Syndrome</m> @DISEASE_MESH:D018746 @@@systemic inflammatory response syndrome@@@ and a @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ level of >120 mg/dl admitted to an intensive care unit (ICU) were randomised to receive either intravenous infusion of IIT alone (n=11) or combined with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (IIT+@CHEMICAL_Methionine @CHEMICAL_MESH:D008715 @@@MET@@@; n=10) to maintain a @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ level (BGL) of 80-120 mg/dl. ", "citations": {"NLM": "Ansari G, Mojtahedzadeh M, Kajbaf F, Najafi A, Khajavi MR, Khalili H, Rouini MR, Ahmadi H, Abdollahi M. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Adv Ther. 2008 Jul;25(7):681-702. PMID: 18636232", "BibTeX": "@article{18636232, title={How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.}, author={Ansari G and Mojtahedzadeh M and Kajbaf F and Najafi A and Khajavi MR and Khalili H and Rouini MR and Ahmadi H and Abdollahi M}, journal={Adv Ther}, volume={25}, number={7}, pages={681-702}}"}}]}